The CNS DLBCL-specific miR-26a downregulation that we present here is also in line with the previous studies suggesting an MYC-miR-26a-EZH2 positive feedback loop in aggressive B-NHLs [52]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma of the central nervous system.